id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-2252-0002,FDA,FDA-2020-N-2252,BsUFA II interim assessment transcript,Other,Transcript(s),2021-02-01T05:00:00Z,2021,2,2021-02-01T05:00:00Z,,2021-02-01T18:48:17Z,,0,0,0900006484a1290b